Insider Shareholders with Direct Ownership of Adverum Biotechnologies, Inc. (ADVM)
This section provides a comprehensive overview of the insiders with direct ownership of Adverum Biotechnologies, Inc. (ADVM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Adverum Biotechnologies, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Julie Clark
Chief Medical Officer |
120,000 | 4,766 | 164,723 $726,428 | 2 |
Sep 30, 2021
Reduced 2.81%
|
Angela Thedinga
Chief Technology Officer |
150,000 | 0 | 150,000 $661,500 | 1 |
Aug 06, 2021
Added 50.0%
|
130,000 | 0 | 130,000 $573,300 | 1 |
Feb 07, 2024
Added 50.0%
|
|
Brigit Riley
Chief Scientific Officer |
0 | 14,565 | 117,435 $517,888 | 2 |
Mar 15, 2023
Reduced 5.85%
|
100,000 | 0 | 100,000 $441,000 | 1 |
Feb 07, 2024
Added 50.0%
|
|
Leone D Patterson
President and CFO |
0 | 12,533 | 97,955 $431,981 | 1 |
Feb 09, 2021
Reduced 0.06%
|
Laurent Fischer
CEO, PRESIDENT AND DIRECTOR |
773,600 | 82,321 | 96,614 $426,067 | 9 |
Feb 25, 2025
Added 20.56%
|
20,000 | 0 | 88,182 $388,882 | 2 |
Mar 24, 2021
Added 10.19%
|
|
50,000 | 0 | 50,000 $220,500 | 2 |
May 16, 2022
Added 37.5%
|
|
Peter Soparkar
CHIEF OPERATING OFFICER |
280,050 | 26,665 | 42,114 $185,722 | 6 |
Feb 25, 2025
Added 23.76%
|
Richard Beckman
Chief Medical Officer |
35,000 | 4,272 | 39,061 $172,259 | 3 |
Sep 19, 2022
Reduced 9.86%
|
Rupert D'Souza
Chief Financial Officer |
20,000 | 0 | 20,850 $91,948 | 2 |
May 17, 2022
Added 32.41%
|
Linda M Rubinstein
CHIEF FINANCIAL OFFICER |
108,125 | 0 | 19,325 $85,223 | 2 |
Feb 25, 2025
Added 29.6%
|
Thomas Woiwode
Director |
12,783 | 0 | 18,822 $83,005 | 1 |
Dec 14, 2020
Added 40.45%
|
Setareh Seyedkazemi
CHIEF DEVELOPMENT OFFICER |
61,458 | 12,259 | 14,692 $64,791 | 5 |
Feb 25, 2025
Added 35.61%
|
Rabia Gurses Ozden
Chief Medical Officer |
8,125 | 0 | 8,125 $35,831 | 1 |
Feb 25, 2025
Added 50.0%
|